Mkts

Mangoceuticals, Inc.

NASDAQ: MGRX
$0.15-0.01 (-9.00%)
As of Nov 18, 2:50 PM ET

Key statistics

Day range
0.140.17
52-week range
0.151.39
Today
Open0.17
Previous close0.15
Volume—
Valuation
Market cap3.56M
P/E ratio—
EPS (TTM)-1.14
Income & risk
Dividend / yield—
Beta2.42
Avg volume9.35M
Discussion

MGRX News

Stories mentioning MGRX from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue68.0095.0084.00168.00109.00106.00133.00163.00
Cost of Goods Sold8.008.002.0019.0025.0020.0022.0030.00
Gross Profit29.0047.0051.0090.0062.0080.0083.0070.00
Operating Expenses
Research & Development
Sales General & Admin
Total Operating Expenses3,155693.007,5945,3584,6381,7581,8412,238
Operating Income (Loss)(3,126)(645.00)(7,543)(5,268)(4,576)(1,677)(1,758)(2,169)
Interest Income
Interest Expense
Other Expense
Pretax Income(3,403)(2,769)(7,619)(5,416)(4,839)(1,948)(2,000)(2,391)
Tax Provision
Net Income (Loss)(3,403)(2,770)(7,618)(5,416)(4,839)(1,948)(1,999)(2,391)
Earnings Per Share (Basic)(0.22)0.21(0.69)(0.57)(1.12)(0.98)(1.14)(1.37)
Earnings Per Share (Diluted)(0.22)(0.28)(0.69)(0.57)(1.12)(0.98)(1.14)(1.37)
Weighted Average Shares Outstanding (Basic)16,48211,5244,5931,9792,0141,740
Weighted Average Shares Outstanding (Diluted)16,48210,07211,5249,9834,5931,9792,0141,740

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About MGRX

Mangoceuticals, Inc. (NASDAQ: MGRX) is a stock listed on the Nasdaq Stock Market under the ticker symbol MGRX. It last traded at $0.1500 (Nov 18, 2026, 2:50 PM ET), down 9.0% on the day. That gives Mangoceuticals a market capitalisation of $3.6M.

Over the past 52 weeks MGRX has traded between $0.1500 and $1.39.

Revenue for the quarter ended Mar 31, 2026 was $68.0K; a net loss of $3.4M. Revenue was down 37.6% from $109.0K in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$68.0K-$3.4M-5004.4%
Dec 31, 2025$95.0K-$2.8M-2915.8%
Sep 30, 2025$84.0K-$7.6M-9069.0%
Jun 30, 2025$168.0K-$5.4M-3223.8%

From Mangoceuticals’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…